FDA approves first at-home device for depression. What is it?

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...

FDA moves to expand sunscreen options, proposing ingredient used in Asia and Europe

The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...

Testosterone levels have declined in men. Here's what the FDA wants to do about it

NPR's Steve Inskeep speaks with FDA Commissioner Martin Makary about the decline in testosterone in men in the U.S. and what ...

FDA proposes allowing sunscreen ingredient already used in Europe and Asia

The Food and Drug Administration announced a proposal Thursday to make another sunscreen ingredient available to U.S.

FDA proposes adding sunscreen ingredient commonly used in other parts of the world to list of permitted products

A new proposal from the US Food and Drug administration would allow sunscreens in the United States to include bemotrizinol ...

FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

FDA panel calls to loosen restrictions on testosterone replacement therapy

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

These moms are thankful for SSRIs during pregnancy. Now the drugs are an FDA flashpoint.

Medical experts are concerned that a panel discussion convened by the Food and Drug Administration could lead to more cases ...